Skip to main content
. Author manuscript; available in PMC: 2019 Nov 6.
Published in final edited form as: J Thorac Oncol. 2018 Jul 17;13(9):1393–1399. doi: 10.1016/j.jtho.2018.05.002

Table 2.

Outcomes Based on PD-L1 Expression at the Stromal Interface (n = 20)

PD-L1 Status n PFS, mo (95% CI) OS, mo (95% CI)
Positive 8 6.5 (1.1–12.8) 12.8 (1.1–17.6)
Negative 12 1.3 (0.6–2.5) 7.6 (2.0–12.7)

PD-L1, programmed death ligand 1; PFS, progression-free survival; CI, confidence interval; OS, overall survival.